Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
September 19, 2006

Bentley Inks Deal with Cardinal Health

  • Bentley Pharmaceuticals secured capacity at Cardinal Health’s new North Raleigh, NC-based facility for the scaleup and manufacture of clinical supplies of Bentley’s intranasal insulin product candidate.

    The product candidate utilizes Bentley’s CPE-215® drug delivery technology to deliver insulin directly through diabetic patients’ nasal mucosa using a nasal spray.

  • You’re all set! Thank you for subscribing to GEN Highlights.